DONOR-SPECIFIC ANTIBODIES (DSA) DETECTED BY C1Q AND C3D ASSAYS PREDICT ANTIBODY-MEDIATED REJECTION (AMR) IN RENAL TRANSPLANT (TX) PATIENTS, BUT SPECIFIC DETECTION OF IGG2, IGG3, IGG4, IGA, AND IGM DSA, AND ANTI-AT1R AND ANTI-ETAR ANTIBODIES DO NOT.

Rhodes-Clark, B; Pandey, S; Harville, T

HUMAN IMMUNOLOGY, 2017; 78 ( ): 18